comparemela.com

Latest Breaking News On - Syndicate department - Page 1 : comparemela.com

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

WINSTON-SALEM, N.C., June 11, 2024 ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an.

North carolinaUnited statesNew yorkWinston salemBruce culletonEthan holdawayJp morgan securitiesBroadridge financial solutionsGuggenheim securitiesGlobenewswire incLifesci advisorsEquity syndicate departmentExchange commissionProkidney corpEquity syndicate prospectus departmentSyndicate prospectus department

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional American Depositary Shares - Structure Therapeutics (NASDAQ:GPCR)

SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and

New yorkUnited statesDanielle keatleyExchange commissionSyndicate departmentEquity syndicate prospectus departmentMorgan stanleyGoldman sachs coEquity syndicate departmentMorgan stanley coProspectus departmentStructure therapeutics incCapital markets corpGuggenheim securitiesStructure therapeuticsLeerink partners

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional American Depositary Shares

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional American Depositary Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkDanielle keatleyDan budwickCapital markets corpMorgan stanley coEquity syndicate prospectus departmentSyndicate departmentGuggenheim securitiesMorgan stanleyStructure therapeutics incEquity syndicate departmentExchange commissionGoldman sachs coProspectus departmentTherapeutics announces closing

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

SAN FRANCISCO, June 05, 2024 Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary.

United statesNew yorkDan budwickDanielle keatleyEquity syndicate prospectus departmentMorgan stanley coSyndicate departmentEquity syndicate departmentStructure therapeutics incGuggenheim securitiesExchange commissionCapital markets corpMorgan stanleyProspectus departmentGoldman sachs coStructure therapeutics

Dynex Capital, Inc Announces Pricing of Public Offering of Common Stock

Dynex Capital, Inc. announced today that it priced its underwritten public offering of 10,500,000 shares of common stock for total expected gross proceeds of approximately $126 million before.

United statesSan franciscoSyndicate departmentDynex capital incExchange commissionDynex capital

vimarsana © 2020. All Rights Reserved.